Prognosis in Patients With Guillain-Barre Syndrome
1 other identifier
observational
450
1 country
1
Brief Summary
The goal of this observational study is to explore significant indicators to predict the early prognosis and late prognosis in patients with Guillain-Barre syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 2, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedFirst Submitted
Initial submission to the registry
December 26, 2022
CompletedFirst Posted
Study publicly available on registry
September 13, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2025
CompletedSeptember 13, 2023
December 1, 2022
9.9 years
December 26, 2022
September 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the severity of Guillain-barre syndrome
The Guillain-Barre syndrome disability score is a wide scale for the severity of Guillain-Barre syndrome (0, optimal health; 1, minor symptoms, able to run; 2, able to walk unaided 10 m, unable to run; 3, able to walk 10 m across an open space with help; 4 bedridden or wheelchair users; 5, require assisted ventilation; 6, dead)(deceased).The higher the score, the worse the prognosis.
baseline, at 1 week, at 26 weeks
Study Arms (2)
mechanical ventilation group
Patients with Guillain-Barré Syndrome require mechanical ventilation during hospitalization
no mechanical ventilation group
Patients with Guillain-Barré Syndrome do not require mechanical ventilation during hospitalization
Eligibility Criteria
This is a multicenter study(approximately three) with over 450 subjects.Clinical data were collected by consulting the patient's electronic history. The data included demographic information, blood biochemical markers, clinical characteristics and electromyography. All participants provided their written informed consent to participate in this study.
You may qualify if:
- patients fulfilled clinical, biological, and electrophysiology criteria for Guillain-barre syndrome.
You may not qualify if:
- nonidiopathic Guillain-barre syndrome and Miller Fisher syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, 325000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 26, 2022
First Posted
September 13, 2023
Study Start
January 2, 2013
Primary Completion
December 1, 2022
Study Completion
January 31, 2025
Last Updated
September 13, 2023
Record last verified: 2022-12